Emilio Bajetta
Monza, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).
Journal: ESMO open
Published: June 04, 2025
Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109).
Journal: ESMO open
Published: November 14, 2024
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 09, 2023
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors.
Journal: JAMA network open
Published: February 24, 2022
Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement.
Journal: Oncology
Published: July 24, 2018
The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor.
Journal: Journal of geriatric oncology
Published: June 22, 2018
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.
Journal: Endocrine-related cancer
Published: March 15, 2018
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Journal: Gastroenterology
Published: March 06, 2017
Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update.
Journal: Neuroendocrinology
Published: January 31, 2017
Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.
Journal: Clinical colorectal cancer
Published: July 15, 2016
Last Updated: 09/26/2026